A review of blood pressure measurement in obese pregnant women by Eley, V. A. et al.
Accepted Manuscript
Review article
A review of blood pressure measurement in obese pregnant women
V.A. Eley, R. Christensen, S. Kumar, L.K. Callaway
PII: S0959-289X(17)30461-2
DOI: https://doi.org/10.1016/j.ijoa.2018.04.004
Reference: YIJOA 2674
To appear in: International Journal of Obstetric Anesthesia
Accepted Date: 15 April 2018
Please cite this article as: Eley, V.A., Christensen, R., Kumar, S., Callaway, L.K., A review of blood pressure
measurement in obese pregnant women, International Journal of Obstetric Anesthesia (2018), doi: https://doi.org/
10.1016/j.ijoa.2018.04.004
This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers
we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and
review of the resulting proof before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
  
Page 1 of 32 
 
 
A review of blood pressure measurement in obese pregnant women 
VA Eley
a,b 
 
R Christensen
a,b
 
S Kumar
b,d 
LK Callaway
b,c 
 
a.  Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women’s 
Hospital, Butterfield St Herston, 2006 Queensland, Australia. 
b.  The University of Queensland, Faculty of Medicine, Herston Road, Herston, 4006 
Queensland, Australia 
c.  Department of Obstetrics and Gynaecology/Obstetric Medicine, The Royal Brisbane and 
Women’s Hospital, Butterfield St Herston, 2006 Queensland, Australia. 
d.   Mater Research Institute and Department of Maternal Fetal Medicine 
The Mater Mothers’ Hospital 
Raymond Terrace, South Brisbane, 4101 
Queensland, Australia 
 
Corresponding author 
  
Page 2 of 32 
 
 
Associate Professor VA Eley, Department of Anaesthesia and Perioperative Medicine, The 
Royal Brisbane and Women’s Hospital, Butterfield St Herston, 2006 Queensland, Australia 
Email address: va_eley@hotmail.com 
 
Keywords: antenatal care; blood pressure measurement; obesity; pregnancy; validation  
Declaration of interests: The authors have no interests to declare 
Funding:  This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
  
  
Page 3 of 32 
 
 
A review of blood pressure measurement in obese pregnant women. 
 
Introduction 
Blood pressure monitoring during pregnancy is important, to detect clinical situations such as 
hypertension and hypotension that require specific interventions. It is essential for clinicians to 
detect both hypertension and hypotension in an accurate and timely fashion.  Conditions causing 
abnormal blood pressure in pregnancy include the hypertensive disorders of pregnancy and 
causes of secondary hypertension, as well as sepsis, major haemorrhage, thromboembolic disease 
and cardiovascular disease. Non-invasive blood pressure measurement is used for the majority of 
women during their antenatal, intrapartum and postnatal care. 
Obese women have an increased risk of experiencing conditions associated with abnormal blood 
pressure, however the morphology of their arms may preclude the appropriate placement and 
function of blood pressure cuffs.
1-3
 The prevalence of maternal obesity is increasing in low, 
middle and high-income countries.
4
 Obesity affects 20% of Australian pregnant women
5
 and 
31% of women of childbearing age in the USA.
6
 The 2017 MBRRACE report on maternal 
morbidity and mortality in the United Kingdom and Ireland identified poor outcomes for obese 
women and the technical difficulties of providing quality care for obese pregnant women.
7
 When 
involved in the operative management of obese pregnant women, anaesthetists have the option of 
direct invasive measurements of arterial blood pressure for improved accuracy. This option is not 
readily available on labour wards, general antenatal or post-natal wards and is inappropriate in 
the antenatal outpatient setting.  While the difficulties of fitting appropriate blood pressure cuffs 
in non-obstetric obese patients is well-addressed in the literature, the similar difficulties that arise 
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in obstetric care are less commonly mentioned. There is no validated alternative technique, for 
this group of women, that may conservatively comprise 1.5% pregnant women in Australia, or 
approximately 4,500 women. 
This topic review will discuss the importance and challenges of blood pressure measurement in 
pregnancy, the equipment available for blood pressure monitoring in pregnancy; and the 
limitations of current device validation protocols in pregnancy.   
 
The importance of blood pressure monitoring in pregnancy  
Hypertension: Blood pressure surveillance is required in the antenatal and postnatal periods, for 
the detection of hypertension in pregnancy. The “hypertensive disorders of pregnancy”8 include 
preeclampsia or eclampsia, gestational hypertension, chronic hypertension and preeclampsia 
superimposed on chronic hypertension.
8
  Hypertension in pregnancy is diagnosed if the systolic 
blood pressure is greater than or equal to 140 mmHg and/or the diastolic blood pressure greater 
than or equal to 90 mmHg.
8
 The diagnosis of preeclampsia is made if the hypertension has an 
onset greater than 20 weeks gestation and is associated with one other organ involvement.
8
 As 
hypertension is frequently the first sign of preeclampsia, accurate measurement of maternal 
blood pressure is critical.  
In Australia preeclampsia affects 5-10% of pregnancies.
5
 Obesity increases the risk of 
developing preeclampsia by three times and up to 4.8 times for those with Class III obesity (body 
mass index (BMI) >40 kg/m
2
).
9
 With obesity affecting over 20% of pregnant women,
5,6,10
 a 
common challenge is to accurately monitor, detect and manage hypertension during pregnancy in 
this at-risk group.  
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As well as having an increased risk of developing preeclampsia, obese women are also more 
likely to have chronic hypertension, and more likely to have hypertension related to obstructive 
sleep apnoea.
11,12
  Other conditions can cause secondary hypertension in pregnancy (renal 
disease, coarctation of the aorta, endocrine and autoimmune disorders).  While these occur less 
commonly, accurate blood pressure monitoring is nevertheless essential for the detection and 
management of these conditions.   
Hypotension: The identification of hypotension and cardiovascular instability in pregnant 
women is also important. Accurate detection of the significant hypotension that may follow 
spinal anaesthesia for caesarean section allows early treatment, which is of benefit to the mother 
and fetus.
13,14
 Hypotension may result from epidural analgesia during labour and also requires 
detection and treatment.  Peripartum sepsis and haemorrhage both require accurate 
haemodynamic monitoring for diagnosis and treatment and are major contributors to maternal 
morbidity and mortality.
5,7
 Obese pregnant women are at a higher risk of both these 
complications compared with non-obese pregnant women.
15,16
 Cardiovascular diseases, including 
those associated with obesity, are a leading cause of indirect maternal mortality and require 
accurate blood pressure monitoring in all phases of pregnancy.
5,7
 Acute hypotension in the 
peripartum period may eventually be managed in a critical care environment that facilitates 
invasive blood pressure monitoring.  However, it is likely that the initial diagnosis will be made 
in a non-critical care environment, utilising non-invasive blood pressure monitoring. 
 
The importance of cuff size in blood pressure measurement 
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Measuring blood pressure using non-invasive arm cuffs is known to be difficult in obese 
patients.
1,3,17
 In addition to the equipment difficulties, the available options for blood pressure 
monitoring techniques in obese pregnant women are also constrained by the context in which the 
monitoring is required.  Currently non-invasive blood pressure monitoring using an auscultatory 
sphygmomanometer or automated oscillotonometric device and an arm cuff is routine in 
antenatal care and on general hospital wards.  This is also true of the labour ward, although many 
hospitals will make provision for invasive monitoring for women with specific co-morbidities.  
Automated oscillotonometric devices using an arm cuff are used intraoperatively for the majority 
of caesarean sections, however invasive monitoring is readily available and feasible, as in the 
intensive care environment. 
All non-invasive devices rely on adequate arm cuff size and fit in order to provide accurate 
readings.
3
 Applying a cuff that is too small will overestimate blood pressure
18,19
 and using a cuff 
that is too large will result in erroneously low readings.
20
  “Under-cuffing” of large arms 
(choosing a cuff that is too small) has been observed to account for 83% of erroneous cuff 
selections.
21
  In maternity care, the implications of this are significant – obese patients, who are 
more likely to be “under-cuffed”, have a higher risk of being diagnosed with hypertension and 
may receive unnecessary treatment.
19
 On the other hand, in these patients an accurate diagnosis 
of hypotension may be delayed.   
Recommended cuff sizes are based on the mid-arm circumference (MAC), provided by the 
American Heart Association (AHA) Scientific Statement: Recommendations for Blood Pressure 
Measurement in Humans and Experimental Animals Part 1: Blood Pressure Measurement in 
Humans published by Pickering et al in 2005 (Table 1).
3
  The MAC is measured at the mid-point 
of the line between the acromion process and the olecranon process.
22
  Anthropomorphic data 
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from 2007 to 2010
23
 suggest that 25.3% of adult (non-pregnant) women in the USA required a 
large cuff (intended for MAC 35-44 cm)
3
 and 2.8% required a thigh cuff (recommended if the 
MAC is greater than 44 cm).
3
  Weight gain during pregnancy, which is commonly outside of the 
recommended weight-gain ranges of 5 to 18kg,
24-26
 has the potential to increase the MAC in 
pregnant women.  
An appropriately sized cuff should have a bladder length that is 80% of the arm circumference 
and a width at least 40% of arm circumference,
3
 although it has been identified that a width of 
46% of the arm circumference is preferred.
3,27
 The bladder length is not obvious to clinicians, as 
it in encased in an outer cloth case. In obese individuals, if the arm is short as well as having a 
large circumference, there may not be an appropriately sized cuff that meets these criteria.
3,17
  
Both “large” and “thigh” sized cuffs are the same width as the standard adult cuff, leading to a 
suboptimal width ratio in these cuffs, whilst the optimal length ratio is maintained in all cuff 
sizes (Table 1).
3
   
 
The accuracy of non-invasive blood pressure monitoring in obese pregnant women 
There are limited published data regarding arm and cuff size that are specific to pregnant women.  
The proportion of women with MAC >44 cm varies according to population variables such as 
ethnicity and socioeconomic status.
23
  In a sample of 179 pregnant women, Hogan et al. found 
that 14.5% required a large cuff (35-44 cm) based on their MAC.
28
 In 220 pregnant women, Kho 
et al. found that the difference in blood pressure readings obtained from a standard cuff or large 
arm cuff increased with increasing arm circumference.
18
  They found that 5-7% of women were 
misdiagnosed with hypertension when a standard cuff was used.
18
  Similarly, Schoenfeld et al. 
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demonstrated the overestimation of blood pressure when an inappropriately-sized arm cuff was 
used.
19
  In a sample of 196 pregnant women, 10% were diagnosed with hypertension when a 
standard cuff was applied, compared with 3% when the recommended cuff size was used.
19
  The 
maximum MAC in the above studies were 44.5 cm (Schoenfeld
19
) and 42 cm (Hogan
28
).  Pilot 
data from our institution found that 13.5% of women after 32 weeks gestation required a large 
cuff, 1.5% required a thigh cuff and the maximum arm circumference was 56.3cm.  The AHA 
recommendations do not cater for patients with a MAC greater than 52 cm.
3
   
Clinical practice guidelines describe how to measure blood pressure accurately in pregnancy.
8,29
  
The mercury sphygmomanometer is considered the gold standard device in pregnancy.
8
 
Guidelines from the Society of Obstetric Medicine of Australia and New Zealand (SOMANZ)
8
 
specify that “the woman should be seated comfortably with her legs resting on a flat surface and 
her arm resting at the level of her heart”. Consistent with the AHA Scientific Statement by 
Pickering et al.,
3
 the SOMANZ guidelines recommend the use of a thigh cuff in pregnant women 
with an arm circumference greater than 44 cm.
8
 Conversely, guidelines from the National 
Institute of Clinical Excellence in the United Kingdom are less specific, simply stating that a 
“cuff of appropriate size” should be used.29 No recommendation is made for the circumstance in 
which no suitably sized cuff is available.  However, the studies by Hogan,
28
 Kho
18
 and 
Schoenfeld
19
 et al. demonstrate the importance of cuff size in determining blood pressure 
readings in pregnancy.   
The AHA Scientific Statement acknowledges that, because poorly-fitting arm cuffs overestimate 
blood pressure in patients with very large arms, the cuff should be instead placed on the forearm 
and the return of the radial pulse palpated at the wrist.
3
  It states: “The accuracy of these methods 
has not been validated, but they provide at least a general estimate of the systolic blood 
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pressure.” This technique presents a problem with antenatal blood pressure surveillance in 
women with very large arms, when the diagnosis of preeclampsia is determined by strict criteria 
for raised systolic and/or diastolic pressure.
8
 In non-pregnant patients, blood pressure readings 
taken from standard rectangular cuffs applied to a forearm, have consistently been found to 
provide readings greater than those taken from a standard cuff applied to the arm.
30,31
  It is 
apparent that while providing a clinical “work around”, such techniques are insufficient for 
accurately detecting and managing abnormalities of blood pressure in obese pregnant women, 
who have the potential for significant maternal and neonatal mortality and morbidity.  
The challenge of cuff selection in obese patients is not just related to the size of the cuff, but also 
to the shape of the arm.  This has been well described in non-pregnant populations (“funnel”32 or 
“conical”2, 33 arms) in which the bladder within the cuff expands irregularly against the arm, due 
to the arm being of a conical shape (Fig. 1).  The “trono-conical” arm shape was described in a 
non-pregnant population by Bonso et al.
34
 using the “conicity index” (CI). This was calculated 
using the proximal arm diameter D1 (below the axilla), the distal arm diameter (above the 
antecubital fossa) and the arm length L, using the equation: CI = 100 x (D1-D2)/L.  In their 
sample of 142, the proximal arm diameter was always greater than the distal arm diameter, 
indicating that all subjects had some degree of conicity in their arm shape. Palatini et al. 
subsequently showed that arm circumference and arm length best predicted conicity in 
individuals of both gender.
2
 These observations have led to the manufacture and testing of trono-
conical cuffs that tend to produce lower blood pressure readings by 2-4 mmHg when compared 
with rectangular cuffs.
2, 35
 However these are not widely available to all clinicians. Recently, a 
biomedical simulation and analysis hypothesised that in obese individuals, the thickened layer of 
subcutaneous fat in the arm reduces the effective transmission of pressure from the cuff to the 
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brachial artery.
36
 This would account for the overestimation of blood pressure readings observed 
in obese pregnant women,
18,19
 but needs further evaluation.  
Other cuffs hold promise for use in obese women but have not been validated for use in 
pregnancy.  A single rigid conical cuff tested by Bonso et al.
34
 on a range of arm circumferences 
from 22 to 45 cm, passed all three phases of testing in non-pregnant adults. Rather than 
providing different cuff sizes, the Visomat Comfort 20/40™ device was designed to use a single 
cuff, on arms ranging from 23-43 cm circumference.
37
 This device estimated the circumference 
of the arm during inflation of the cuff and a microprocessor adjusted the recorded blood pressure 
based on that estimate. Further evaluations in pregnant patients and in patients with arms of 
greater circumference are required. Oscillotonometric devices that utilise cuffs around the wrist 
or finger have been assessed and are available, but continue to be considered less accurate than 
those devices that use arm cuffs.
3,30,38
 However, a conical wrist cuff designed by GE 
Healthcare™, specifically for obese patients, was tested in subjects with an arm circumference 
greater than 40 cm and showed good agreement with invasive radial arterial monitoring.
39
  Like 
the innovations described above, the requirement for validation in a pregnant population
38
 has 
not been met. 
 
An overview of blood pressure monitoring devices in pregnancy. 
Clinical guidelines
8
 and authorities
40-42
 providing validation protocols agree that blood pressure 
monitoring devices that are intended for use in pregnancy must be validated first in a pregnant 
population that preferably includes preeclamptic women.
40
  This stipulation is based on the 
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significant haemodynamic changes which occur during pregnancy and the abnormal 
cardiovascular state that co-exists in preeclampsia.
40
 
There have been many technological advances in non-invasive blood pressure measurement 
since 1896, when Riva-Rocci described the use of a mercury sphygmomanometer that identified 
systolic blood pressure only, by palpation of the pulse.
43
  In 1905, Korotkoff introduced the use 
of auscultation to determine systolic and diastolic blood pressure.
44
 While the mercury 
sphygmomanometer is still considered the gold standard for non-invasive blood pressure 
measurement by auscultation in pregnancy, aneroid or hybrid manometers are more frequently 
used due to concerns about occupational exposure to mercury. The first sound heard (K1) is 
recommended as that representing systolic pressure and K5 (or K4 if K5 absent) as that 
representing diastolic pressure.
8
 The rate of cuff deflation (≤ 2 mmHg/s) is important to avoid 
underestimation of the systolic pressure.
3
 
Currently, automated oscillotonometric devices are most likely to be used by anaesthetists in the 
perioperative environment and post-anaesthesia care unit if invasive monitoring is not indicated. 
The “Device for Indirect Non-Invasive Automatic Mean Arterial Pressure (Dinamap™)”45-47 was 
introduced in 1976 and refers to the first widely used automated oscillotonometric method of 
measuring blood pressure, obtained from measurements of changes in arm cuff pressure.  The 
mean arterial pressure and systolic pressure are measured according to changes of oscillation in 
the cuff as it deflates, and the diastolic pressure is calculated according to an algorithm.
46,47
 A 
recent systematic review examined validation studies performed in normotensive and 
hypertensive pregnant women.
48
 Only five of 14 of the devices intended for clinic use (as 
opposed to home blood pressure monitoring use) were validated according to approved protocols 
and were without protocol violations.
48-51
 Protocol violations were categorised as major (such as 
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including an incorrect number of participants, or an incorrect number of comparisons) or minor 
(such as including an incorrect range of systolic or diastolic blood pressure readings, or an 
inadequate arm circumference range).  The successfully validated devices included the A&D 
UM101™ (an auscultatory hybrid sphygmomanometer),50 the Omron HEM907™ (an automated 
oscillotonometric device),
50
 the Nissei DS-400™ (a semi-automated oscillotonometric device for 
low-resource settings),
51
 the Omron MIT Elite™ (an automated oscillotonometric device)49 and 
the Dinamap Procare 400™ (an automated oscillotonometric device).52 All of these, other than 
the Dinamap Procare 400™ were validated in pre-eclamptic pregnant women. None of these 
devices were validated in pregnant women with arms of MAC greater than 42 cm. The strengths 
and limitations of the different methods of measuring blood pressure in pregnancy are shown in 
Table 2. 
 
Invasive monitoring 
Arterial monitoring is the gold standard for invasive blood pressure monitoring and measures 
peripheral blood pressure.  In the clinical setting this involves the insertion of an intra-arterial 
catheter, most commonly into the radial artery.  This catheter is connected to a pressure 
transducer which must be appropriately levelled and zeroed to provide accurate beat-to-beat 
measurements of systolic, diastolic and mean blood pressure.  In the anaesthetic care of pregnant 
women, invasive monitoring may be indicated for patient co-morbidities such as obstructive 
cardiac lesions, intracranial pathology, severe preeclampsia or during major obstetric 
haemorrhage.  In severe preeclampsia, managing cerebral perfusion pressure is critical and 
placement of the arterial pressure transducer will influence the reading acquired.
53
  Narrative 
reviews describe obesity as an indicator for invasive arterial monitoring due to the unreliability 
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of non-invasive monitoring techniques in patients with very large arms, as demonstrated in Fig. 
1.
54-56
 The benefits of invasive arterial monitoring include the provision of continuous blood 
pressure readings, particularly at times of haemodynamic instability, and the opportunity for 
blood sampling.  The potential complications range from site haematoma or infections to 
systemic sepsis, arterial thromboses or emboli.  Other limitations are practical - invasive 
monitoring requires a clinician to insert the line and appropriately trained staff to monitor the 
catheter.  For these reasons, invasive arterial monitoring is typically used only in critical care 
areas – emergency departments, operating theatres and intensive care units.  Such monitoring 
cannot feasibly be used in an outpatient setting or be continued on a regular postnatal or 
postoperative ward. 
 
Non-invasive continuous blood pressure measurements using the volume clamp method of 
Penaz 
There are two well-known devices that use this technology and are available for clinical use.  
These are the ClearSight™ device (Edwards Lifesciences, Irvine, California 92614, USA; 
previously known as Nexfin™ or Finapres™) and the CNAP™ device (continuous non-invasive 
arterial pressure, CNSystems Medizintechnik AG, Graz, Austria).  They are both based on the 
volume-clamp method of Penaz
57
 which was developed in the 1970s. The devices measure the 
change in blood volume within the finger using photo-plethysmography, and those changes are 
converted into a continuous blood pressure waveform.  Both devices apply their own proprietary 
algorithm: Physiocal
58
 in the case of ClearSight™ and the VERIFI-algorithm59 by the CNAP™.  
While based on the same technology, there are some differences between these devices (Table 
2).  The ClearSight™ uses disposable cuffs, either as a single cuff (for up to 8 hours of use) or 
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two cuffs which operate alternately, to potentially prolong the monitoring period to 72 hours.  
The CNAP™ comes as a re-usable, double-finger cuff which measures alternately on adjacent 
fingers and can monitoring for up to 24 hours.  Both devices provide three different cuff sizes: 
the ClearSight™ caters for a maximum finger circumference of 6.8 cm, whereas the CNAP 
monitor can fit a maximum finger circumference of 8.8 cm. Fig. 2 shows the ClearSight™ finger 
cuff and monitor. Both devices require calibration. The ClearSight™ ‘heart reference sensor” is 
calibrated at the level of the right atrium and the CNAP™ has three options for calibration – 1. 
according to an empiric reference value 2. according to values manually entered by the operator 
3. according to a non-invasive blood pressure reading obtained from a CNAP™ arm cuff (to suit 
maximum MAC of 40 cm). 
The ClearSight™ monitor has been examined in cardiothoracic anaesthesia,60-62 elective general 
surgery
63
 and orthopaedic surgery.
64
 The agreement between ClearSight™ measurements and 
both invasive
60,61
 and non-invasive
64
 measurements in non-pregnant populations is good. None 
of the published validation studies have been undertaken in obese populations. One validation 
study of the ClearSight™ was performed in pregnant women weighing 45-103 kg65 who had a 
MAC range of 20-37 cm.  The device passed two of the three phases of the European Society for 
Hypertension (ESH) International Protocol 2002.
66
 Edwards Lifesciences™ state that “the 
effectiveness of the ClearSight finger cuff has not been established in pre-eclamptic patients.”67 
Other publications reveal that the ClearSight™ is being used clinically and for research 
purposes, as an alternative to invasive monitoring in anaesthesia for caesarean section.
68,69
   
The indications for the CNAP™, as described by CNSystems, include “monitoring the impact of 
a medical procedure on blood pressure” and “blood pressure monitoring of ill or circulatory 
unstable patients”; and it is approved for use in preeclampsia.70  Published studies in non-
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pregnant patients have demonstrated good agreement with invasive mean arterial pressure
71,72
, 
with less agreement during the post-induction period or during periods of hypotension.
71
  Studies 
in pregnant women have largely occurred at elective caesarean section performed under spinal 
anaesthesia
73-75
 and have demonstrated reasonable correlation, however the requirement for 
frequent calibration in the awake patient (using the device’s arm cuff) was described as a 
significant limitation.
73
  None of these studies included women with a BMI greater than 40 kg/m
2 
or woman with preeclampsia. Two studies undertaken in patients undergoing weight-loss surgery 
(BMI ranges 38 to 75 kg/m
2 76 
and 37 to 68 kg/m
2
)
77 
found good trending ability, but the absolute 
blood pressure values provided by the CNAP™ correlated poorly with invasive 
measurements.
76,77
 Tobias et al. reported that the CNAP™ finger cuffs fitted poorly in this very 
obese population and that the device’s arm cuff was too small, requiring placement on the 
forearm in half their participants.
76
  Forearm placement resulted in reduced accuracy of the 
device.
 
The application of a finger-cuff in obese pregnant women, instead of an arm cuff, would avoid 
the need to select an appropriate arm cuff and the potential resultant blood pressure measurement 
inaccuracies. The inclusion of the relatively small arm-cuff as a calibrating tool for the CNAP™ 
monitor reduces its utility in obese patients.  As non-invasive techniques, both the devices have 
fewer associated risks and complications and could be used in non-critical-care environments.  
The currently available finger-cuff sizes may be inadequate for obese women, particularly with 
the peripheral oedema that may occur in pregnancy. Another limitation is the significant cost of 
the device (and the consumables for the ClearSight™). To be an acceptable alternative to current 
practice, these devices require specific evaluation and validation in an obese, pregnant 
population. 
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There are other devices for measuring blood pressure, which are not used widely in clinical 
practice and have not been validated in pregnant populations.  These include the use of doppler 
ultrasound at the radial artery and radial artery tonometry.
3
 Radial applanation tonometry and 
carotid applanation tonometry aim to provide estimations of central blood pressure from pressure 
measurements taken at the radial artery or carotid artery.
78
 The accuracy of these devices is 
reduced when using non-invasive blood pressure arm cuffs for calibration.
78
 The relevance of 
central blood pressure readings in pregnancy is unclear. 
 
Challenges of validating blood pressure monitoring devices in pregnancy  
The currently available validation protocols for blood pressure measurement devices in 
pregnancy are compared in Table 3.  The updated version of the European Society of 
Hypertension International Protocol was published in 2010
79
 and relaxed the range of systolic 
blood pressures (≤100 to ≥ 170 mmHg) included in the protocol and the age range to greater than 
25 years. The authors of that protocol advocated its use in pregnant women and obese 
individuals.  An important but non-specific caveat was made about the appropriate sample size, 
indicating that for some populations 33 individuals will not be sufficient.  It is unclear if women 
with severe hypertension can be treated and retained within the validation protocol.  
The British Hypertension Society protocol,
41
 published in 1993, described a limited pregnancy 
protocol in 30 subjects, in which the device had already been evaluated in 85 subjects according 
to the non-pregnant adult protocol (Table 3).  The pregnancy protocol recommended the 
inclusion of patients with a maximum systolic pressure of 160 mmHg and that 8-10 of the 30 
subjects have an arm circumference greater than 35 cm.
41
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The updated Association of the Advancement of Medical Instrumentation (AAMI) protocol, 
published in 2013,
40
 included a pregnancy-specific protocol that also addressed preeclampsia. 
The majority of validation studies in pregnant women apply the European Society of 
Hypertension
 
protocol
79
 or the British Hypertension Society protocol
41
 in subject selection, with 
many additionally applying the maximum permissible mean error criteria of the AAMI protocol 
(±5 mmHg mean error and standard deviation ≤8 mmHg).40 The AAMI protocol provides the 
most specific advice regarding arm circumference.
40
  While also providing the most specific 
guidance on the inclusion of preeclamptic women, it applies outdated criteria for preeclampsia.
40
  
Proteinuria is no longer essential for the diagnosis of preeclampsia
8
 and when measured, is most 
likely to be done using a spot urine protein/creatinine ratio, with a cut-off  value of ≥ 30 
mg/mmol being considered equivalent to 300 mg/day by the 24-hour collection method.
8,80
 
There are some difficulties in validating devices in obese pregnant women. Table 3 indicates that 
pregnant women with an arm circumference >44 cm are not required to be included in the 
validation samples of these protocols.  As the gold standard (mercury sphygmomanometer) is 
thought to be inaccurate in an obese population,
18,19
 what should the reference standard be?
38
  
The use of invasive arterial blood pressure to validate a new technology is associated with 
difficulties – ethical considerations will limit those in whom intra-arterial catheterisation is 
clinically indicated and the staffing and equipment required necessitate monitoring in a critical 
care or operating theatre environment.
38
 While invasive arterial monitoring is considered a valid 
alternative gold-standard in the AAMI protocol,
40
 the others only specify mercury 
sphygmomanometers.
41,79
 There are ethical concerns in the currently available validation studies 
in pregnant women, when the presence of a systolic pressure > 160mmHg in preeclampsia 
necessitates urgent management to avoid disastrous complications such as intracerebral 
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haemorrhage.
8
  In validation studies on non-pregnant patients, this is not as crucial, as it is 
presumed that the cerebral circulation has compensated for the higher perfusion pressure.  
The AAMI protocol stipulates that blood pressure monitoring devices used for pregnant women 
must be validated in a pregnant population that preferably includes women with preeclampsia.
40
 
This requirement is based on the significant haemodynamic changes which occur during 
pregnancy and the abnormal cardiovascular state that co-exists in preeclampsia.
40
 It also reflects 
the need for devices that are able to perform accurately under these conditions of physiological 
perturbation.  It is clear that a universally accepted and more detailed pregnancy-specific 
protocol is required, using current criteria for preeclampsia and catering for the physiological 
changes in pregnancy.  As demonstrated by the meta-analysis by Bello et al.,
48
 compliance with 
protocol standards when devices are validated in pregnancy must improve.  The ideal protocol 
would allow for the simultaneous treatment of severe hypertension.  Such a protocol must be 
feasible to undertake in pregnancy and meet the needs of important subsets of the pregnant 
population: women of reproductive age including those aged between 15 and 50 years; those 
with arms greater than 44 cm circumference; those with a high BMI; and those with 
preeclampsia. The development and regulation of such a protocol would be complex and require 
a multidisciplinary effort, but we should acknowledge that it is urgently required.   
The European Society of Hypertension Working Group on Blood Pressure Monitoring and 
Cardiovascular Variability published a position statement in 2016
38
 that acknowledged the issues 
of cylindrical cuffs causing inaccuracy in obese patients; and noted that further work is required 
in validating devices in patients with large arms.  This statement also recognised the requirement 
for defining the validation requirements of special populations, including the pregnant 
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population.  Clinicians caring for obese pregnant women can add their voice to these concerns 
and seek solutions to this significant clinical problem. 
 
Can we improve current practice? 
There are currently few alternatives for clinicians when blood pressure cuffs do not fit obese 
pregnant women.  Despite knowing the importance of accurate blood pressure surveillance in 
pregnancy, clinicians are forced to revert to sub-optimal alternatives such as taking 
measurements on the forearm or leg, which are not validated techniques.
3 
 To avoid this, new 
devices must be validated in not just pregnant populations, but in populations of obese pregnant 
women and those with preeclampsia.  Devices that have the potential to improve the accuracy of 
blood pressure surveillance in obese pregnant women, but have not been validated in this 
population, include trono-conical cuffs
34
 that account for the conical shape of some arms; 
software algorithms in modern automatic oscillotonometric devices that use a single cuff, but 
compensate for arm circumference;
37
 and photoplethysmography devices using the finger-clamp 
method of Penaz
57
 (for example the CNAP™73 or ClearSight™65 monitors) which have a finger-
cuff and avoid the problems associated with arm shape and circumference. 
 
Conclusion 
Blood pressure surveillance is a critical component of antenatal and peripartum care and 
healthcare providers need to have confidence in the measuring devices used. Obese women are 
particularly at risk of abnormalities of blood pressure in pregnancy and these conditions can 
influence maternal and neonatal morbidity.  Current measuring equipment is inadequate for 
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around 1.5% of the pregnant women due to the shape and size of their arms – this is known to 
reduce the accuracy of monitoring in this at-risk group.  Technical innovations exploring cuff 
shape, microprocessor technology and finger cuffs have been explored in the non-obstetric 
population, but are either not validated for, or have not been adopted for, the care of pregnant 
women. We must bring the advantages of new technologies to our pregnant patients and 
facilitate the evaluation and adoption of new and beneficial devices, with a view to improving 
maternal and neonatal outcomes. 
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Figure Legends 
Fig. 1.  The large arm circumference and conical shape of this patient’s arm precluded cuff 
placement on the arm.  Antenatal and postoperative blood pressure measurement was obtained 
using a large cuff on the forearm.  During her caesarean section an arterial line was utilised. 
Fig. 2.  The ClearSight™ non-invasive continuous blood pressure device, showing a medium-
sized finger-cuff and the arterial waveform on the monitor. 
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Table 1.  Recommendations on the cuff bladder size according to arm circumference.
7
 
 
Arm circumference (cm) Bladder length (cm) Bladder width (cm) 
22-26   small 22 12 
27-34   standard 30 16 
35-44   large 36 16
a
 
45-52   thigh 42 16
a
 
 
a. The bladder width does not change for the large and thigh cuffs because of the practical difficulties in 
applying very wide cuffs and the limitations of arm length.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Table 2.  The strengths and limitations of the different methods of non-invasive blood pressure measurement in pregnancy; 
Method of 
measurement 
Validation status Strengths Limitations Context for use Opportunities 
Auscultatory 
sphygmomanometer 
Remains the gold 
standard in 
pregnancy. Hybrid 
devices are replacing 
mercury devices.  
Algorithms not 
utilised. 
Depends on appropriate 
cuff size and arm shape.  
 
Dependent on user 
technique and hearing 
acuity. 
Outpatient and inpatient 
care; use during labour. 
Specifically- 
shaped cuffs for 
trono-conical arms. 
 
Automated 
oscillotonometric 
devices  
Selected devices 
have been validated 
in pregnant 
populations.  
 
Not all devices are 
validated for use in 
preeclampsia. 
Not dependent on user 
technique or hearing 
acuity. 
 
Low risk of 
complications. 
Depends on appropriate 
cuff size and arm shape. 
 
Algorithms used to 
calculate diastolic 
pressure. 
 
 
Outpatient and inpatient 
care; perioperative care; 
use during labour. 
Specifically- 
shaped cuffs for 
trono-conical arms. 
 
Microprocessors 
that calculate the 
blood pressure, 
taking into account 
the MAC. 
Photoplethysmography 
using the finger-clamp 
method of Penaz
44 
 
     
CNAP™ Studied in the setting 
of caesarean section 
under spinal 
anaesthesia. 
Not dependent on the 
MAC and shape of 
the arm. 
 
Re-usable finger-cuffs 
on two adjacent 
fingers. 
 
Provides continuous 
blood pressure 
readings. 
 
Low risk of 
complications 
(potential soft tissue 
injury). 
 
Uses proprietary 
algorithms. 
 
Frequent calibration 
against an 
oscillotonometric arm 
cuff.  
 
Accompanying arm cuff 
suits maximum MAC of 
40 cm. 
 
Maximum cuff 
circumference 8.8 cm 
 
Measurement artefact in 
awake patients. 
 
Currently recommended 
for: 
“Monitoring the impact of 
a medical procedure on 
blood pressure.” 
“Blood pressure 
monitoring of ill or 
circulatory unstable 
patients” 
 
Up to 24 hours continuous 
use 
Feasible for 
outpatient; 
inpatient; 
perioperative; and 
use during labour. 
 
Requires further 
evaluation in 
pregnancy, outside 
of the operating 
theatre. 
 
Requires validation 
in obese pregnant 
women. 
 
  
 
      
ClearSight™ Studied in one 
outpatient pregnant 
population, passed 
two of three 
validation phases. 
 
Has not been 
assessed in 
preeclampsia. 
 
Not dependent on the 
MAC and shape of 
the arm. 
 
Provides continuous 
blood pressure 
readings. 
 
Low risk of 
complications 
(potential soft tissue 
injury). 
 
Can use single or dual 
cuffs. 
Uses proprietary 
algorithms. 
 
Requires appropriate 
calibration. 
 
Range of cuff sizes may 
be inadequate; maximum 
cuff circumference 6.8 
cm. 
 
Costly consumables. 
 
Measurement artefact in 
awake patients. 
 
 
Currently largely used in 
the perioperative and 
intensive care setting. 
 
Limited to eight hours use 
for a single cuff, up to 72 
hours use if two cuffs are 
used. 
 
Feasible for 
outpatient, 
inpatient, 
perioperative, and 
labour usage. 
 
Requires further 
evaluation in 
pregnancy and in 
obese pregnant 
women. 
Direct intra-arterial 
catheterisation 
Considered the gold 
standard of invasive 
monitoring. 
Not dependent on the 
MAC and shape of 
the arm. 
 
Provides continuous 
blood pressure 
readings. 
 
Allows for blood 
sampling. 
 
 
 
Amplification can result 
in overestimation of 
systolic pressures. 
 
Must be appropriately 
zeroed and levelled. 
 
Risk of infection, 
haematoma, thromboses 
or emboli. 
 
Insertion may be 
technically difficult in 
obese pregnant women 
and require ultrasound 
guidance. 
 
Restricted to perioperative 
and critical care 
environments. 
 
MAC = mean arm circumference 
 
  
Table 3.  Features of the three available protocols for the validation of blood pressure measurement devices in pregnancy 
Protocol Sample 
size 
Age 
range 
Diastolic blood 
pressure range 
(DBP) 
Systolic blood 
pressure range (SBP) 
Arm circumference 
European Society 
of Hypertension 
2010
33
 
33 >25 y ≤50 to ≥120 
mmHg 
≤100 to 
≥170 mmHg 
The bladder must be of sufficient length to 
encircle 80%–100% of the arm circumference a 
British 
Hypertension 
Society 1993
32
 
30 No 
suggestion 
70 to 105 mmHg 100 to 160 mmHg 8-10 subjects with arm circumference >35 cm 
AMMI
b
 
2013 
45 
(15 in 
each 
sub-
group) 
No 
suggestion 
Normotensive   SBP <140, DBP < 90               
mmHg 
 
“At least 40% of the subjects shall have a limb 
circumference which lies within the upper half 
of the specified range of use of the cuff and at 
least 40% shall have a limb circumference 
within the lower half.” 
 
“At least 20% of the subjects shall have a limb 
circumference which lies within the upper 
quarter of the specified range of use of the cuff 
and at least 20% shall have a limb 
circumference within the lower quarter.” 
Hypertensive    SBP ≥140, DBP ≥ 90 
mmHg 
                          No proteinuria 
Hypertensive    DBP ≥ 90 mmHg 
                          Proteinuria > 300 mg/24 h 
 
a.  It is unclear how individuals might be managed if there is no cuff of sufficient size or shape  
b.  AAMI = Association of the Advancement of Medical Instrumentation 
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Highlights 
 Obese women have a high risk of abnormal blood pressure in pregnancy 
 Accurate blood pressure surveillance in pregnancy is essential 
 Accuracy can be compromised by poorly-fitting arm cuffs in obese women 
 Alternatives to non-invasive monitoring using arm cuffs are available 
 Protocol violations are common in validation studies of devices in pregnancy  
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